# bluebird bio acquires Durham manufacturing facility for $11.5M

bluebird bio acquired a 125,000-square-foot manufacturing facility in Durham, North Carolina, for $11.5 million to produce lentiviral vectors for its cell and gene therapies.

- Type: Acquisition
- Announced: 2017-11-29
- Where: Durham, North Carolina, United States
- Value: $11.5M
- Status: announced
- Capacity: 125,000 sq ft facility
- Products: lentiviral vectors for cell and gene therapies
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [bluebird bio](https://endata.com/companies/20764.md) (acquirer)

## Sources

- [genengnews.com](https://www.genengnews.com/topics/genome-editing/bluebird-bio-acquires-durham-nc-manufacturing-site-for-lentiviral-vector-production/), 2017-11-29: "Investing in a world-class manufacturing infrastructure is a crucial step in accomplishing that mission on behalf of the people who need these novel treatments."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.